Biopharmaceuticals are therapeutic substances produced using living organisms. According to Allied Market Research, the global biopharmaceuticals market accounted for approximately $186 billion in 2017 and is projected to reach $526 billion by 2025. The Asia Pacific (APAC) harbors the third-largest biopharmaceutical market in the
MoreBiopharmaceuticals are defined as substances produced in living systems by biotechnology and
Unlike generic medicines where the active ingredients are identical, biosimilars – by
SOMERSET, N.J. — Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies,
More
Biopharmaceuticals are therapeutic substances produced using living organisms. According to Allied Market Research, the global biopharmaceuticals market accounted for approximately
More
According to MarketsandMarkets, the global pharmaceutical contract development and manufacturing market is projected to reach USD 126.63 billion by 2024
More
Modern scientific firms are involved in everything from crop variety preservation to genetic research and therapeutic medicine. One of the
More
Protect biologics and complex molecules from leachables and extractables with new packaging materials. The global biologic drug market is projected
More
Unlike generic medicines where the active ingredients are identical, biosimilars – by definition – are not likely to be identical
More
A biologic medicine is a large molecule typically derived from living cells and used in the treatment, diagnosis or prevention
More
Biopharmaceuticals are defined as substances produced in living systems by biotechnology and used for therapeutic purposes or in vivo diagnostics.
More